LIVSANE Xylo PLUS, Nasenspray, Lösung
7680702760018
CH-70276
Nasenspray
Associated product:
LIVSANE Xylo PLUS, Nasenspray, Lösung
1 / 3
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- ml
- Galenic form
- Nasenspray
- Galenic group
- Nasenmittel
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MGML | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
100.0 UG | Substance | WIZUS |
|
(N/A)
|
50.0 MGML | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
5.0 MG | Substance | WIZUS |
|
dinatrii phosphas dodecahydricus
|
- | Substance | HNIDK |
|
kalii dihydrogenophosphas
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Pharmapost AG
3098 Köniz
Authorization information
- Swissmedic authorization number
- 70276
- Drug name
- LIVSANE Xylo PLUS, Nasenspray, Lösung
- Galenic form
- NASSL
- ATC Code
- R01AB06
- Authorization status
- Z
- Authorization category
- Category C
- Dispensing category
- D
- First authorization
- 05/06/2025
- Authorization expiration date
- 31/12/9999
- IT Number
- 12.02.2.
- Domain
- Human medicine
Package details
- Description (FR)
- LIVSANE Xylo PLUS nasal spray 1 mg/ml 10 ml
- Description (DE)
- LIVSANE Xylo PLUS Nasenspray 1 mg/ml 10 ml
- Market launch
- 01/12/2025
- Narcotic (BTM)
- No